⌘K

Login Start Free

Home/Filings/4/0001033408-10-000002

4//SEC Filing

MCNEILL JOHN A JR 4

Accession 0001033408-10-000002

CIK 0001003124other

View on SEC.gov Company Profile

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 1:52 PM ET

Size

20.9 KB

Accession

0001033408-10-000002

Insider Transaction Report

Form 4

Period: 2010-03-23

PHARMACEUTICAL PRODUCT DEVELOPMENT INCPPDI

MCNEILL JOHN A JR

Director

Transactions

Exercise/Conversion
Common Stock
2010-03-23$4.50/sh+16,000$72,000→ 78,512 total
Exercise/Conversion
Stock Options (to buy)
2010-03-23−16,000→ 0 total
Exercise: $4.50From: 2000-05-16Exp: 2010-05-15→ Common Stock (0 underlying)

Holdings

Stock Options (to buy)
Exercise: $19.86From: 2009-05-20Exp: 2019-05-20→ Common Stock (13,577 underlying)
13,577
Common Stock
(indirect: By Trust)
2,613,942
Common Stock
(indirect: By LLC)
1,195
Common Stock
(indirect: By Partnership)
365,485
Stock Options (to buy)
Exercise: $42.77From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,265 underlying)
6,265
Stock Options (to buy)
Exercise: $12.81From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,000 underlying)
12,000
Stock Options (to buy)
Exercise: $23.79From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,458 underlying)
5,458
Stock Options (to buy)
Exercise: $35.38From: 2006-05-17Exp: 2016-05-16→ Common Stock (3,973 underlying)
3,973
Stock Options (to buy)
Exercise: $15.82From: 2001-05-15Exp: 2011-05-14→ Common Stock (8,000 underlying)
8,000
Stock Options (to buy)
Exercise: $33.82From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,126 underlying)
6,126
Stock Options (to buy)
Exercise: $13.58From: 2003-05-14Exp: 2013-05-13→ Common Stock (16,000 underlying)
16,000

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

Entity typeother

Related Parties

1

filerCIK 0001033408

Filing Metadata

Form type: 4
Filed: Mar 22, 8:00 PM ET
Accepted: Mar 23, 1:52 PM ET
Size: 20.9 KB

View on SEC.gov